Documents

A list of downloadable documents created during development.

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: equality impact assessment - guidance development

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: final appraisal determination

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: response to consultee and commentator comments on the provisional matrix - June 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: response to consultee and commentator comments on the draft remit and draft scope - June 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: final scope - June 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: final matrix - June 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: equality impact assessment - scoping - June 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: appendix B - provisional matrix February 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: appendix A - draft scope for consultation February 2012

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: appendix B - draft scope for consultation (pre-referral) July 2011